This Article Full Text Full Text (PDF) All Versions of this Article: 90/6/3528    most recent Author Manuscript (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sakhaee, K. Articles by Pak, C. Y. C. Search for Related Content PubMed PubMed Citation Articles by Sakhaee, K. Articles by Pak, C. Y. C. Related Collections Calcium and Bone Metabolism Female Endocrinology

Effects of Potassium Alkali and Calcium Supplementation on Bone Turnover in Postmenopausal Women

Center for Mineral Metabolism and Clinical Research (K.S., N.M.M., C.Y.C.P.), University of Texas Southwestern Medical Center, Dallas, Texas 75390-8885; and Department of Pediatrics (S.A.A.), Children’s Nutrition Research Center, Baylor College of Medicine, Houston, Texas 77030-2600

Address all correspondence and requests for reprints to: Khashayar Sakhaee, M.D., 5323 Harry Hines Boulevard, Dallas, Texas 75390-8885. E-mail: khashayar.sakhaee{at}email.swmed.edu.

Potassium citrate may improve calcium balance by conferring an alkali load. Calcium supplementation slows postmenopausal bone loss by inhibiting PTH secretion. This study explores whether combined treatment with potassium citrate and calcium citrate is more effective than either agent alone in inhibiting bone loss. In a crossover study involving 18 postmenopausal women, the following treatments were compared: potassium citrate (4.3 g or 40 mmol/d), calcium citrate (800 mg or 20 mmol/d), combined treatment, and placebo. During the last 2 d of each 2-wk phase, serum and 24-h urine were collected for assessment of calcium metabolism, alkali load, and bone turnover markers. Compared with placebo, potassium citrate provided an alkali load and significantly decreased urinary calcium without changing serum PTH (sPTH) or bone turnover markers. Calcium citrate significantly increased absorbed calcium, marginally decreased sPTH, and significantly reduced bone resorption markers. Combined treatment retained key features of potassium citrate and calcium citrate. However, more alkali was delivered than with potassium citrate alone, and absorbed calcium did not differ from calcium citrate alone. Compared with placebo, combined treatment increased urinary calcium, marginally reduced sPTH, provided a clear alkali load, and reduced the bone resorption markers serum type I collagen C-telopeptide and urinary N-telopeptide by 20.4% (P < 0.0001) and 18.2% (P = 0.005), respectively. A significant trend was noted for the decrease in bone resorption markers as treatment changed from placebo to potassium citrate to calcium citrate to combined treatment. In postmenopausal women, combined treatment with potassium citrate and calcium citrate inhibits bone resorption by providing an alkali load and increasing absorbed calcium.

This article has been cited by other articles:

				H. M Macdonald, A. J Black, L. Aucott, G. Duthie, S. Duthie, R. Sandison, A. C Hardcastle, S. A Lanham New, W. D Fraser, and D. M Reid Effect of potassium citrate supplementation or increased fruit and vegetable intake on bone metabolism in healthy postmenopausal women: a randomized controlled trial Am. J. Clinical Nutrition, August 1, 2008; 88(2): 465 - 474. [Abstract] [Full Text] [PDF]

				O. Bonny, A. Rubin, C.-L. Huang, W. H. Frawley, C. Y.C. Pak, and O. W. Moe Mechanism of Urinary Calcium Regulation by Urinary Magnesium and pH J. Am. Soc. Nephrol., August 1, 2008; 19(8): 1530 - 1537. [Abstract] [Full Text] [PDF]

				A. J. Felsenfeld and B. S. Levine Milk Alkali Syndrome and the Dynamics of Calcium Homeostasis Clin. J. Am. Soc. Nephrol., July 1, 2006; 1(4): 641 - 654. [Full Text] [PDF]